ConductScience.org, home

Paper17570972

Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.

Mahmoudzadeh-Niknam H and 2 others. Korean J Parasitol, 2007. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Papers, record 17570972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17570972

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.
PubMed
Journal
Korean J Parasitol
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2019-06-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahmoudzadeh-Niknam HHamid
2Kiaei SSSimin Sadat
3Iravani DDavood

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypersensitivity, DelayedMajor topic
Leishmania majorMajor topic
Leishmania tropicaMajor topic
Leishmaniasis, CutaneousMajor topic
Animals
Disease Models, Animal
Ear
Female
Foot
Mice
Mice, Inbred BALB C

Source PubMed

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,801,669CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.J Immunol2002https://conductscience.org/library/papers/11801669PubMed
29,676,711Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.Exp Parasitol1998https://conductscience.org/library/papers/9676711PubMed
315,172,223Leishmania tropica: cysteine proteases are essential for growth and pathogenicity.Exp Parasitol2004https://conductscience.org/library/papers/15172223PubMed
415,196,239Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.Clin Exp Immunol2004https://conductscience.org/library/papers/15196239PubMed
515,271,920Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major.Infect Immun2004https://conductscience.org/library/papers/15271920PubMed
66,447,751Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.J Exp Med1980https://conductscience.org/library/papers/6447751PubMed
73,160,663Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis.Infect Immun1985https://conductscience.org/library/papers/3160663PubMed
83,160,786Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.J Immunol1985https://conductscience.org/library/papers/3160786PubMed
93,818,088Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.Infect Immun1987https://conductscience.org/library/papers/3818088PubMed
103,562,057The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.Parasite Immunol1987https://conductscience.org/library/papers/3562057PubMed
113,295,049Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.J Immunol1987https://conductscience.org/library/papers/3295049PubMed
121,636,090Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.Science1992https://conductscience.org/library/papers/1636090PubMed
138,249,076The clinical and immunological spectrum of American cutaneous leishmaniasis.Trans R Soc Trop Med Hyg1993https://conductscience.org/library/papers/8249076PubMed
148,932,762Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice.Exp Parasitol1996https://conductscience.org/library/papers/8932762PubMed
1514,527,520Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.Int J Parasitol2003https://conductscience.org/library/papers/14527520PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41,181,203Evaluation of Apoptotic Effect of Transgenic Leishmania tropica Expressing MLLO-Bax-Smac Fusion Gene in Infected Macrophages, an In Vitro Study.Iran J Parasitol2025https://conductscience.org/library/papers/41181203PubMed
39,528,528Expression of key cytokines in dog macrophages infected by Leishmania tarentolae opening new avenues for the protection against Leishmania infantum.Sci Rep2024https://conductscience.org/library/papers/39528528PubMed
36,296,160Interspecies and Intrastrain Interplay among Leishmania spp. Parasites.Microorganisms2022https://conductscience.org/library/papers/36296160PubMed
30,248,142Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.PLoS One2018https://conductscience.org/library/papers/30248142PubMed
26,334,763A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/26334763PubMed
23,467,583The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice.Korean J Parasitol2013https://conductscience.org/library/papers/23467583PubMed
22,961,311Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.Parasitol Res2013https://conductscience.org/library/papers/22961311PubMed
18,165,706Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.Korean J Parasitol2007https://conductscience.org/library/papers/18165706PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17570972

GET https://conductscience.org/api/papers/v1/17570972/authors